Pirfenidone and nintedanib in fibrosing interstitial lung disease: A retrospective study based on a regional university hospital data registry and literature review
Int. Journal of Clinical Pharmacology and Therapeutics · 01.09.2026 · 64 (09) · 459-469
DOI: 10.5414/cp204921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.09.2026. Verfasst von Carla Sans-Pola und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pyridones, Indoles, Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Sans-Pola, C., Boy, R., Villar, A., Ojanguren, I., Simeón-Aznar, C. P., Guillen-Del-Castillo, A., Vancells, G., Agustí, A., & Danés, I. (2026). Pirfenidone and nintedanib in fibrosing interstitial lung disease: A retrospective study based on a regional university hospital data registry and literature review. Int. Journal of Clinical Pharmacology and Therapeutics, 64(09), 459-469. https://doi.org/10.5414/cp204921
Vancouver
Sans-Pola C, Boy R, Villar A, Ojanguren I, Simeón-Aznar CP, Guillen-Del-Castillo A, et al. Pirfenidone and nintedanib in fibrosing interstitial lung disease: A retrospective study based on a regional university hospital data registry and literature review. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(09):459-469. doi:10.5414/cp204921
BibTeX
@article{SansPola2026,
author = {Sans-Pola, Carla and Boy, Ricardo and Villar, Ana and Ojanguren, Iñigo and Simeón-Aznar, Carmen Pilar and Guillen-Del-Castillo, Alfredo and Vancells, Guillem and Agustí, Antònia and Danés, Immaculada},
title = {Pirfenidone and nintedanib in fibrosing interstitial lung disease: A retrospective study based on a regional university hospital data registry and literature review},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {09},
pages = {459--469},
doi = {10.5414/cp204921}
}
EUVIMED